Literature DB >> 8239658

Human erythrocyte casein kinase II: characterization and phosphorylation of membrane cytoskeletal proteins.

T Wei1, M Tao.   

Abstract

Casein kinase II activities were purified from human erythrocyte membrane and cytosolic fractions to apparent homogeneity. The kinases isolated from the membrane and cytosolic fractions exhibited the same subunit composition and the ability to utilize ATP and GTP as phosphoryl donors. Antibodies against the alpha and alpha' subunits of human casein kinase II cross reacted with the corresponding subunits of both erythrocyte casein kinases. Spermine, spermidine, putrescine, and polylysine stimulated to varying degrees the activities of erythrocyte casein kinase II, whereas heparin inhibited the kinase activities. Both kinases were found to catalyze the phosphorylation of several erythrocyte membrane cytoskeletal proteins, including spectrin, ankyrin, adducin, protein 4.1, and protein 4.9. Unlike casein kinase I, casein kinase II did not phosphorylate band 3 appreciably. A preliminary estimate indicates that both human erythrocyte membrane and cytosolic casein kinase II catalyze the incorporation of approximately 1.2 and 3.5 moles of phosphate into each mole of spectrin and ankyrin, respectively. An analysis of the phosphopeptide maps of ankyrin indicates that both membrane and cytosolic kinases phosphorylate the same domains within ankyrin. These data, taken together, suggest that the type II casein kinases isolated from human erythrocyte membrane and cytosol are either identical or closely related and may play a role in the regulation of cytoskeletal protein interactions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239658     DOI: 10.1006/abbi.1993.1580

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  CK2 interacting proteins: emerging paradigms for CK2 regulation?

Authors:  Mary Ellen K Olsten; Jane E Weber; David W Litchfield
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

Review 2.  Ecto-protein kinase CK2, the neglected form of CK2.

Authors:  Mathias Montenarh; Claudia Götz
Journal:  Biomed Rep       Date:  2018-02-21

3.  Treatment of cultured human astrocytes and vascular endothelial cells with protein kinase CK2 inhibitors induces early changes in cell shape and cytoskeleton.

Authors:  A A Kramerov; A G Golub; V G Bdzhola; S M Yarmoluk; K Ahmed; M Bretner; A V Ljubimov
Journal:  Mol Cell Biochem       Date:  2010-12-02       Impact factor: 3.396

4.  Ligation of complement receptor 1 increases erythrocyte membrane deformability.

Authors:  Aleksandra M Glodek; Rossen Mirchev; David E Golan; Joseph A Khoory; Jennie M Burns; Sergey S Shevkoplyas; Anne Nicholson-Weller; Ionita C Ghiran
Journal:  Blood       Date:  2010-09-22       Impact factor: 22.113

5.  Stimulation in vitro of vitamin B12-dependent methionine synthase by polyamines.

Authors:  S H Kenyon; A Nicolaou; T Ast; W A Gibbons
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

6.  Phosphorylation of membrane proteins in erythrocytes treated with lead.

Authors:  L Belloni-Olivi; M Annadata; G W Goldstein; J P Bressler
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.